Global Neurotransmitter Inhibitor Peptides Supply, Demand and Key Producers, 2026-2032
The global Neurotransmitter Inhibitor Peptides market size is expected to reach $ 142 million by 2032, rising at a market growth of 5.7% CAGR during the forecast period (2026-2032).
Neurotransmitter Inhibitor Peptides are bioactive cosmetic peptides designed to reduce the release or activity of neurotransmitters involved in facial muscle contraction, especially acetylcholine-related signaling. In skincare, they are mainly used as topical anti-aging ingredients to soften expression lines and dynamic wrinkles by modulating SNARE-complex formation, SNAP-25-related signaling, or neuromuscular communication; typical examples include acetyl hexapeptide-8 and acetyl octapeptide-3.
In 2025, global Neurotransmitter Inhibitor Peptides production reached approximately 13,824 kg, with an average global market price of around US$ 6,800 per kg. The production capacity of Neurotransmitter Inhibitor Peptides is approximately 17 tons per year, the average gross profit margin was 31-33%.
The upstream supply chain mainly includes amino acids, protected amino-acid derivatives, peptide synthesis reagents, solvents, purification media, stabilizers, and packaging materials. Midstream manufacturers conduct solid-phase peptide synthesis, purification, freeze-drying, formulation stabilization, and quality testing. Downstream demand comes from anti-aging skincare brands, functional cosmetics, cosmeceutical formulators, beauty clinics, OEM/ODM cosmetics manufacturers, and distributors of active cosmetic ingredients.
The cost structure is mainly composed of peptide synthesis raw materials, coupling reagents, solvents, purification and separation costs, quality-control testing, freeze-drying, formulation stabilization, labor, energy, packaging, regulatory compliance, and R&D expenses. For high-purity or modified peptides, purification, yield loss, analytical testing, and synthesis complexity usually account for a large share of total cost.
This report studies the global Neurotransmitter Inhibitor Peptides production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurotransmitter Inhibitor Peptides and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurotransmitter Inhibitor Peptides that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurotransmitter Inhibitor Peptides total production and demand, 2021-2032, (kg)
Global Neurotransmitter Inhibitor Peptides total production value, 2021-2032, (USD Million)
Global Neurotransmitter Inhibitor Peptides production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (kg), (based on production site)
Global Neurotransmitter Inhibitor Peptides consumption by region & country, CAGR, 2021-2032 & (kg)
U.S. VS China: Neurotransmitter Inhibitor Peptides domestic production, consumption, key domestic manufacturers and share
Global Neurotransmitter Inhibitor Peptides production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (kg)
Global Neurotransmitter Inhibitor Peptides production by Type, production, value, CAGR, 2021-2032, (USD Million) & (kg)
Global Neurotransmitter Inhibitor Peptides production by Application, production, value, CAGR, 2021-2032, (USD Million) & (kg)
This report profiles key players in the global Neurotransmitter Inhibitor Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lubrizol (Lipotec), dsm-firmenich, LipoTrue, Spec-Chem Industry, GenScript, Active Peptide Company, Uniproma Chemical, BOC Sciences (AAPEP), GfN Selco, COSROMA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurotransmitter Inhibitor Peptides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (kg) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neurotransmitter Inhibitor Peptides Market, By Region:
1. How big is the global Neurotransmitter Inhibitor Peptides market?
2. What is the demand of the global Neurotransmitter Inhibitor Peptides market?
3. What is the year over year growth of the global Neurotransmitter Inhibitor Peptides market?
4. What is the production and production value of the global Neurotransmitter Inhibitor Peptides market?
5. Who are the key producers in the global Neurotransmitter Inhibitor Peptides market?
6. What are the growth factors driving the market demand?
Neurotransmitter Inhibitor Peptides are bioactive cosmetic peptides designed to reduce the release or activity of neurotransmitters involved in facial muscle contraction, especially acetylcholine-related signaling. In skincare, they are mainly used as topical anti-aging ingredients to soften expression lines and dynamic wrinkles by modulating SNARE-complex formation, SNAP-25-related signaling, or neuromuscular communication; typical examples include acetyl hexapeptide-8 and acetyl octapeptide-3.
In 2025, global Neurotransmitter Inhibitor Peptides production reached approximately 13,824 kg, with an average global market price of around US$ 6,800 per kg. The production capacity of Neurotransmitter Inhibitor Peptides is approximately 17 tons per year, the average gross profit margin was 31-33%.
The upstream supply chain mainly includes amino acids, protected amino-acid derivatives, peptide synthesis reagents, solvents, purification media, stabilizers, and packaging materials. Midstream manufacturers conduct solid-phase peptide synthesis, purification, freeze-drying, formulation stabilization, and quality testing. Downstream demand comes from anti-aging skincare brands, functional cosmetics, cosmeceutical formulators, beauty clinics, OEM/ODM cosmetics manufacturers, and distributors of active cosmetic ingredients.
The cost structure is mainly composed of peptide synthesis raw materials, coupling reagents, solvents, purification and separation costs, quality-control testing, freeze-drying, formulation stabilization, labor, energy, packaging, regulatory compliance, and R&D expenses. For high-purity or modified peptides, purification, yield loss, analytical testing, and synthesis complexity usually account for a large share of total cost.
This report studies the global Neurotransmitter Inhibitor Peptides production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurotransmitter Inhibitor Peptides and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurotransmitter Inhibitor Peptides that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurotransmitter Inhibitor Peptides total production and demand, 2021-2032, (kg)
Global Neurotransmitter Inhibitor Peptides total production value, 2021-2032, (USD Million)
Global Neurotransmitter Inhibitor Peptides production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (kg), (based on production site)
Global Neurotransmitter Inhibitor Peptides consumption by region & country, CAGR, 2021-2032 & (kg)
U.S. VS China: Neurotransmitter Inhibitor Peptides domestic production, consumption, key domestic manufacturers and share
Global Neurotransmitter Inhibitor Peptides production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (kg)
Global Neurotransmitter Inhibitor Peptides production by Type, production, value, CAGR, 2021-2032, (USD Million) & (kg)
Global Neurotransmitter Inhibitor Peptides production by Application, production, value, CAGR, 2021-2032, (USD Million) & (kg)
This report profiles key players in the global Neurotransmitter Inhibitor Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lubrizol (Lipotec), dsm-firmenich, LipoTrue, Spec-Chem Industry, GenScript, Active Peptide Company, Uniproma Chemical, BOC Sciences (AAPEP), GfN Selco, COSROMA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurotransmitter Inhibitor Peptides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (kg) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neurotransmitter Inhibitor Peptides Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- SNARE-Complex Modulating Peptides
- SNAP-25 Mimicking Peptides
- Others
- Unmodified Peptides
- Acetylated Peptides
- Other
- Short-Chain Peptides: 2?4 Amino Acids
- Medium-Chain Peptides: 5?8 Amino Acids
- Long-Chain Peptides: >8 Amino Acids
- Eye Care Products
- Facial Serums
- Face Creams and Lotions
- Other
- Lubrizol (Lipotec)
- dsm-firmenich
- LipoTrue
- Spec-Chem Industry
- GenScript
- Active Peptide Company
- Uniproma Chemical
- BOC Sciences (AAPEP)
- GfN Selco
- COSROMA
- Gene-Biocon
- ChinaPeptides (QYAOBIO)
- Pengting Peptide
- RS Synthesis
- Shenzhen JYMed Technology Co., Ltd.
- Nanjing Peptide Biotech
- AAPPTec
- Tianji Bio-pharmaceutical
- Zhejiang Peptites Biotech
- Guangzhou Tongjun Pharmaceutical Technology
- Hantide Biomedical Group
- Hangzhou Go Top Biotech
1. How big is the global Neurotransmitter Inhibitor Peptides market?
2. What is the demand of the global Neurotransmitter Inhibitor Peptides market?
3. What is the year over year growth of the global Neurotransmitter Inhibitor Peptides market?
4. What is the production and production value of the global Neurotransmitter Inhibitor Peptides market?
5. Who are the key producers in the global Neurotransmitter Inhibitor Peptides market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neurotransmitter Inhibitor Peptides Introduction
1.2 World Neurotransmitter Inhibitor Peptides Supply & Forecast
1.2.1 World Neurotransmitter Inhibitor Peptides Production Value (2021 & 2025 & 2032)
1.2.2 World Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.2.3 World Neurotransmitter Inhibitor Peptides Pricing Trends (2021-2032)
1.3 World Neurotransmitter Inhibitor Peptides Production by Region (Based on Production Site)
1.3.1 World Neurotransmitter Inhibitor Peptides Production Value by Region (2021-2032)
1.3.2 World Neurotransmitter Inhibitor Peptides Production by Region (2021-2032)
1.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Region (2021-2032)
1.3.4 North America Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.5 Europe Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.6 China Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.7 Japan Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.8 India Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.9 Southeast Asia Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurotransmitter Inhibitor Peptides Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurotransmitter Inhibitor Peptides Major Market Trends
2 DEMAND SUMMARY
2.1 World Neurotransmitter Inhibitor Peptides Demand (2021-2032)
2.2 World Neurotransmitter Inhibitor Peptides Consumption by Region
2.2.1 World Neurotransmitter Inhibitor Peptides Consumption by Region (2021-2026)
2.2.2 World Neurotransmitter Inhibitor Peptides Consumption Forecast by Region (2027-2032)
2.3 United States Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.4 China Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.5 Europe Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.6 Japan Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.7 South Korea Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.8 ASEAN Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.9 India Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurotransmitter Inhibitor Peptides Production Value by Manufacturer (2021-2026)
3.2 World Neurotransmitter Inhibitor Peptides Production by Manufacturer (2021-2026)
3.3 World Neurotransmitter Inhibitor Peptides Average Price by Manufacturer (2021-2026)
3.4 Neurotransmitter Inhibitor Peptides Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurotransmitter Inhibitor Peptides Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurotransmitter Inhibitor Peptides in 2025
3.5.3 Global Concentration Ratios (CR8) for Neurotransmitter Inhibitor Peptides in 2025
3.6 Neurotransmitter Inhibitor Peptides Market: Overall Company Footprint Analysis
3.6.1 Neurotransmitter Inhibitor Peptides Market: Region Footprint
3.6.2 Neurotransmitter Inhibitor Peptides Market: Company Product Type Footprint
3.6.3 Neurotransmitter Inhibitor Peptides Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Comparison
4.1.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Comparison
4.2.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Comparison
4.3.1 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.4.3 United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
4.5 China Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share
4.5.1 China Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.5.3 China Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
4.6 Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 SNARE-Complex Modulating Peptides
5.2.2 SNAP-25 Mimicking Peptides
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Neurotransmitter Inhibitor Peptides Production by Type (2021-2032)
5.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Type (2021-2032)
5.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CHEMICAL MODIFICATION
6.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Chemical Modification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Chemical Modification
6.2.1 Unmodified Peptides
6.2.2 Acetylated Peptides
6.2.3 Other
6.3 Market Segment by Chemical Modification
6.3.1 World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2021-2032)
6.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2021-2032)
6.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2032)
7 MARKET ANALYSIS BY PEPTIDE CHAIN LENGTH
7.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Peptide Chain Length: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Peptide Chain Length
7.2.1 Short-Chain Peptides: 2?4 Amino Acids
7.2.2 Medium-Chain Peptides: 5?8 Amino Acids
7.2.3 Long-Chain Peptides: >8 Amino Acids
7.3 Market Segment by Peptide Chain Length
7.3.1 World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2021-2032)
7.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2021-2032)
7.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Eye Care Products
8.2.2 Facial Serums
8.2.3 Face Creams and Lotions
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Neurotransmitter Inhibitor Peptides Production by Application (2021-2032)
8.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Application (2021-2032)
8.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lubrizol (Lipotec)
9.1.1 Lubrizol (Lipotec) Details
9.1.2 Lubrizol (Lipotec) Major Business
9.1.3 Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Product and Services
9.1.4 Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Lubrizol (Lipotec) Recent Developments/Updates
9.1.6 Lubrizol (Lipotec) Competitive Strengths & Weaknesses
9.2 dsm-firmenich
9.2.1 dsm-firmenich Details
9.2.2 dsm-firmenich Major Business
9.2.3 dsm-firmenich Neurotransmitter Inhibitor Peptides Product and Services
9.2.4 dsm-firmenich Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 dsm-firmenich Recent Developments/Updates
9.2.6 dsm-firmenich Competitive Strengths & Weaknesses
9.3 LipoTrue
9.3.1 LipoTrue Details
9.3.2 LipoTrue Major Business
9.3.3 LipoTrue Neurotransmitter Inhibitor Peptides Product and Services
9.3.4 LipoTrue Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 LipoTrue Recent Developments/Updates
9.3.6 LipoTrue Competitive Strengths & Weaknesses
9.4 Spec-Chem Industry
9.4.1 Spec-Chem Industry Details
9.4.2 Spec-Chem Industry Major Business
9.4.3 Spec-Chem Industry Neurotransmitter Inhibitor Peptides Product and Services
9.4.4 Spec-Chem Industry Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Spec-Chem Industry Recent Developments/Updates
9.4.6 Spec-Chem Industry Competitive Strengths & Weaknesses
9.5 GenScript
9.5.1 GenScript Details
9.5.2 GenScript Major Business
9.5.3 GenScript Neurotransmitter Inhibitor Peptides Product and Services
9.5.4 GenScript Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 GenScript Recent Developments/Updates
9.5.6 GenScript Competitive Strengths & Weaknesses
9.6 Active Peptide Company
9.6.1 Active Peptide Company Details
9.6.2 Active Peptide Company Major Business
9.6.3 Active Peptide Company Neurotransmitter Inhibitor Peptides Product and Services
9.6.4 Active Peptide Company Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Active Peptide Company Recent Developments/Updates
9.6.6 Active Peptide Company Competitive Strengths & Weaknesses
9.7 Uniproma Chemical
9.7.1 Uniproma Chemical Details
9.7.2 Uniproma Chemical Major Business
9.7.3 Uniproma Chemical Neurotransmitter Inhibitor Peptides Product and Services
9.7.4 Uniproma Chemical Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Uniproma Chemical Recent Developments/Updates
9.7.6 Uniproma Chemical Competitive Strengths & Weaknesses
9.8 BOC Sciences (AAPEP)
9.8.1 BOC Sciences (AAPEP) Details
9.8.2 BOC Sciences (AAPEP) Major Business
9.8.3 BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Product and Services
9.8.4 BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 BOC Sciences (AAPEP) Recent Developments/Updates
9.8.6 BOC Sciences (AAPEP) Competitive Strengths & Weaknesses
9.9 GfN Selco
9.9.1 GfN Selco Details
9.9.2 GfN Selco Major Business
9.9.3 GfN Selco Neurotransmitter Inhibitor Peptides Product and Services
9.9.4 GfN Selco Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 GfN Selco Recent Developments/Updates
9.9.6 GfN Selco Competitive Strengths & Weaknesses
9.10 COSROMA
9.10.1 COSROMA Details
9.10.2 COSROMA Major Business
9.10.3 COSROMA Neurotransmitter Inhibitor Peptides Product and Services
9.10.4 COSROMA Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 COSROMA Recent Developments/Updates
9.10.6 COSROMA Competitive Strengths & Weaknesses
9.11 Gene-Biocon
9.11.1 Gene-Biocon Details
9.11.2 Gene-Biocon Major Business
9.11.3 Gene-Biocon Neurotransmitter Inhibitor Peptides Product and Services
9.11.4 Gene-Biocon Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Gene-Biocon Recent Developments/Updates
9.11.6 Gene-Biocon Competitive Strengths & Weaknesses
9.12 ChinaPeptides (QYAOBIO)
9.12.1 ChinaPeptides (QYAOBIO) Details
9.12.2 ChinaPeptides (QYAOBIO) Major Business
9.12.3 ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Product and Services
9.12.4 ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 ChinaPeptides (QYAOBIO) Recent Developments/Updates
9.12.6 ChinaPeptides (QYAOBIO) Competitive Strengths & Weaknesses
9.13 Pengting Peptide
9.13.1 Pengting Peptide Details
9.13.2 Pengting Peptide Major Business
9.13.3 Pengting Peptide Neurotransmitter Inhibitor Peptides Product and Services
9.13.4 Pengting Peptide Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Pengting Peptide Recent Developments/Updates
9.13.6 Pengting Peptide Competitive Strengths & Weaknesses
9.14 RS Synthesis
9.14.1 RS Synthesis Details
9.14.2 RS Synthesis Major Business
9.14.3 RS Synthesis Neurotransmitter Inhibitor Peptides Product and Services
9.14.4 RS Synthesis Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 RS Synthesis Recent Developments/Updates
9.14.6 RS Synthesis Competitive Strengths & Weaknesses
9.15 Shenzhen JYMed Technology Co., Ltd.
9.15.1 Shenzhen JYMed Technology Co., Ltd. Details
9.15.2 Shenzhen JYMed Technology Co., Ltd. Major Business
9.15.3 Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Product and Services
9.15.4 Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Shenzhen JYMed Technology Co., Ltd. Recent Developments/Updates
9.15.6 Shenzhen JYMed Technology Co., Ltd. Competitive Strengths & Weaknesses
9.16 Nanjing Peptide Biotech
9.16.1 Nanjing Peptide Biotech Details
9.16.2 Nanjing Peptide Biotech Major Business
9.16.3 Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.16.4 Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Nanjing Peptide Biotech Recent Developments/Updates
9.16.6 Nanjing Peptide Biotech Competitive Strengths & Weaknesses
9.17 AAPPTec
9.17.1 AAPPTec Details
9.17.2 AAPPTec Major Business
9.17.3 AAPPTec Neurotransmitter Inhibitor Peptides Product and Services
9.17.4 AAPPTec Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 AAPPTec Recent Developments/Updates
9.17.6 AAPPTec Competitive Strengths & Weaknesses
9.18 Tianji Bio-pharmaceutical
9.18.1 Tianji Bio-pharmaceutical Details
9.18.2 Tianji Bio-pharmaceutical Major Business
9.18.3 Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Product and Services
9.18.4 Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Tianji Bio-pharmaceutical Recent Developments/Updates
9.18.6 Tianji Bio-pharmaceutical Competitive Strengths & Weaknesses
9.19 Zhejiang Peptites Biotech
9.19.1 Zhejiang Peptites Biotech Details
9.19.2 Zhejiang Peptites Biotech Major Business
9.19.3 Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.19.4 Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Zhejiang Peptites Biotech Recent Developments/Updates
9.19.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
9.20 Guangzhou Tongjun Pharmaceutical Technology
9.20.1 Guangzhou Tongjun Pharmaceutical Technology Details
9.20.2 Guangzhou Tongjun Pharmaceutical Technology Major Business
9.20.3 Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Product and Services
9.20.4 Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Guangzhou Tongjun Pharmaceutical Technology Recent Developments/Updates
9.20.6 Guangzhou Tongjun Pharmaceutical Technology Competitive Strengths & Weaknesses
9.21 Hantide Biomedical Group
9.21.1 Hantide Biomedical Group Details
9.21.2 Hantide Biomedical Group Major Business
9.21.3 Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Product and Services
9.21.4 Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Hantide Biomedical Group Recent Developments/Updates
9.21.6 Hantide Biomedical Group Competitive Strengths & Weaknesses
9.22 Hangzhou Go Top Biotech
9.22.1 Hangzhou Go Top Biotech Details
9.22.2 Hangzhou Go Top Biotech Major Business
9.22.3 Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.22.4 Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Hangzhou Go Top Biotech Recent Developments/Updates
9.22.6 Hangzhou Go Top Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neurotransmitter Inhibitor Peptides Industry Chain
10.2 Neurotransmitter Inhibitor Peptides Upstream Analysis
10.2.1 Neurotransmitter Inhibitor Peptides Core Raw Materials
10.2.2 Main Manufacturers of Neurotransmitter Inhibitor Peptides Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Neurotransmitter Inhibitor Peptides Production Mode
10.6 Neurotransmitter Inhibitor Peptides Procurement Model
10.7 Neurotransmitter Inhibitor Peptides Industry Sales Model and Sales Channels
10.7.1 Neurotransmitter Inhibitor Peptides Sales Model
10.7.2 Neurotransmitter Inhibitor Peptides Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Neurotransmitter Inhibitor Peptides Introduction
1.2 World Neurotransmitter Inhibitor Peptides Supply & Forecast
1.2.1 World Neurotransmitter Inhibitor Peptides Production Value (2021 & 2025 & 2032)
1.2.2 World Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.2.3 World Neurotransmitter Inhibitor Peptides Pricing Trends (2021-2032)
1.3 World Neurotransmitter Inhibitor Peptides Production by Region (Based on Production Site)
1.3.1 World Neurotransmitter Inhibitor Peptides Production Value by Region (2021-2032)
1.3.2 World Neurotransmitter Inhibitor Peptides Production by Region (2021-2032)
1.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Region (2021-2032)
1.3.4 North America Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.5 Europe Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.6 China Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.7 Japan Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.8 India Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.3.9 Southeast Asia Neurotransmitter Inhibitor Peptides Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurotransmitter Inhibitor Peptides Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurotransmitter Inhibitor Peptides Major Market Trends
2 DEMAND SUMMARY
2.1 World Neurotransmitter Inhibitor Peptides Demand (2021-2032)
2.2 World Neurotransmitter Inhibitor Peptides Consumption by Region
2.2.1 World Neurotransmitter Inhibitor Peptides Consumption by Region (2021-2026)
2.2.2 World Neurotransmitter Inhibitor Peptides Consumption Forecast by Region (2027-2032)
2.3 United States Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.4 China Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.5 Europe Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.6 Japan Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.7 South Korea Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.8 ASEAN Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
2.9 India Neurotransmitter Inhibitor Peptides Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurotransmitter Inhibitor Peptides Production Value by Manufacturer (2021-2026)
3.2 World Neurotransmitter Inhibitor Peptides Production by Manufacturer (2021-2026)
3.3 World Neurotransmitter Inhibitor Peptides Average Price by Manufacturer (2021-2026)
3.4 Neurotransmitter Inhibitor Peptides Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurotransmitter Inhibitor Peptides Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurotransmitter Inhibitor Peptides in 2025
3.5.3 Global Concentration Ratios (CR8) for Neurotransmitter Inhibitor Peptides in 2025
3.6 Neurotransmitter Inhibitor Peptides Market: Overall Company Footprint Analysis
3.6.1 Neurotransmitter Inhibitor Peptides Market: Region Footprint
3.6.2 Neurotransmitter Inhibitor Peptides Market: Company Product Type Footprint
3.6.3 Neurotransmitter Inhibitor Peptides Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Comparison
4.1.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Comparison
4.2.1 United States VS China: Neurotransmitter Inhibitor Peptides Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neurotransmitter Inhibitor Peptides Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Comparison
4.3.1 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Neurotransmitter Inhibitor Peptides Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.4.3 United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
4.5 China Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share
4.5.1 China Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.5.3 China Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
4.6 Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 SNARE-Complex Modulating Peptides
5.2.2 SNAP-25 Mimicking Peptides
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Neurotransmitter Inhibitor Peptides Production by Type (2021-2032)
5.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Type (2021-2032)
5.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CHEMICAL MODIFICATION
6.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Chemical Modification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Chemical Modification
6.2.1 Unmodified Peptides
6.2.2 Acetylated Peptides
6.2.3 Other
6.3 Market Segment by Chemical Modification
6.3.1 World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2021-2032)
6.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2021-2032)
6.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2032)
7 MARKET ANALYSIS BY PEPTIDE CHAIN LENGTH
7.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Peptide Chain Length: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Peptide Chain Length
7.2.1 Short-Chain Peptides: 2?4 Amino Acids
7.2.2 Medium-Chain Peptides: 5?8 Amino Acids
7.2.3 Long-Chain Peptides: >8 Amino Acids
7.3 Market Segment by Peptide Chain Length
7.3.1 World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2021-2032)
7.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2021-2032)
7.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neurotransmitter Inhibitor Peptides Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Eye Care Products
8.2.2 Facial Serums
8.2.3 Face Creams and Lotions
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Neurotransmitter Inhibitor Peptides Production by Application (2021-2032)
8.3.2 World Neurotransmitter Inhibitor Peptides Production Value by Application (2021-2032)
8.3.3 World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lubrizol (Lipotec)
9.1.1 Lubrizol (Lipotec) Details
9.1.2 Lubrizol (Lipotec) Major Business
9.1.3 Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Product and Services
9.1.4 Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Lubrizol (Lipotec) Recent Developments/Updates
9.1.6 Lubrizol (Lipotec) Competitive Strengths & Weaknesses
9.2 dsm-firmenich
9.2.1 dsm-firmenich Details
9.2.2 dsm-firmenich Major Business
9.2.3 dsm-firmenich Neurotransmitter Inhibitor Peptides Product and Services
9.2.4 dsm-firmenich Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 dsm-firmenich Recent Developments/Updates
9.2.6 dsm-firmenich Competitive Strengths & Weaknesses
9.3 LipoTrue
9.3.1 LipoTrue Details
9.3.2 LipoTrue Major Business
9.3.3 LipoTrue Neurotransmitter Inhibitor Peptides Product and Services
9.3.4 LipoTrue Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 LipoTrue Recent Developments/Updates
9.3.6 LipoTrue Competitive Strengths & Weaknesses
9.4 Spec-Chem Industry
9.4.1 Spec-Chem Industry Details
9.4.2 Spec-Chem Industry Major Business
9.4.3 Spec-Chem Industry Neurotransmitter Inhibitor Peptides Product and Services
9.4.4 Spec-Chem Industry Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Spec-Chem Industry Recent Developments/Updates
9.4.6 Spec-Chem Industry Competitive Strengths & Weaknesses
9.5 GenScript
9.5.1 GenScript Details
9.5.2 GenScript Major Business
9.5.3 GenScript Neurotransmitter Inhibitor Peptides Product and Services
9.5.4 GenScript Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 GenScript Recent Developments/Updates
9.5.6 GenScript Competitive Strengths & Weaknesses
9.6 Active Peptide Company
9.6.1 Active Peptide Company Details
9.6.2 Active Peptide Company Major Business
9.6.3 Active Peptide Company Neurotransmitter Inhibitor Peptides Product and Services
9.6.4 Active Peptide Company Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Active Peptide Company Recent Developments/Updates
9.6.6 Active Peptide Company Competitive Strengths & Weaknesses
9.7 Uniproma Chemical
9.7.1 Uniproma Chemical Details
9.7.2 Uniproma Chemical Major Business
9.7.3 Uniproma Chemical Neurotransmitter Inhibitor Peptides Product and Services
9.7.4 Uniproma Chemical Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Uniproma Chemical Recent Developments/Updates
9.7.6 Uniproma Chemical Competitive Strengths & Weaknesses
9.8 BOC Sciences (AAPEP)
9.8.1 BOC Sciences (AAPEP) Details
9.8.2 BOC Sciences (AAPEP) Major Business
9.8.3 BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Product and Services
9.8.4 BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 BOC Sciences (AAPEP) Recent Developments/Updates
9.8.6 BOC Sciences (AAPEP) Competitive Strengths & Weaknesses
9.9 GfN Selco
9.9.1 GfN Selco Details
9.9.2 GfN Selco Major Business
9.9.3 GfN Selco Neurotransmitter Inhibitor Peptides Product and Services
9.9.4 GfN Selco Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 GfN Selco Recent Developments/Updates
9.9.6 GfN Selco Competitive Strengths & Weaknesses
9.10 COSROMA
9.10.1 COSROMA Details
9.10.2 COSROMA Major Business
9.10.3 COSROMA Neurotransmitter Inhibitor Peptides Product and Services
9.10.4 COSROMA Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 COSROMA Recent Developments/Updates
9.10.6 COSROMA Competitive Strengths & Weaknesses
9.11 Gene-Biocon
9.11.1 Gene-Biocon Details
9.11.2 Gene-Biocon Major Business
9.11.3 Gene-Biocon Neurotransmitter Inhibitor Peptides Product and Services
9.11.4 Gene-Biocon Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Gene-Biocon Recent Developments/Updates
9.11.6 Gene-Biocon Competitive Strengths & Weaknesses
9.12 ChinaPeptides (QYAOBIO)
9.12.1 ChinaPeptides (QYAOBIO) Details
9.12.2 ChinaPeptides (QYAOBIO) Major Business
9.12.3 ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Product and Services
9.12.4 ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 ChinaPeptides (QYAOBIO) Recent Developments/Updates
9.12.6 ChinaPeptides (QYAOBIO) Competitive Strengths & Weaknesses
9.13 Pengting Peptide
9.13.1 Pengting Peptide Details
9.13.2 Pengting Peptide Major Business
9.13.3 Pengting Peptide Neurotransmitter Inhibitor Peptides Product and Services
9.13.4 Pengting Peptide Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Pengting Peptide Recent Developments/Updates
9.13.6 Pengting Peptide Competitive Strengths & Weaknesses
9.14 RS Synthesis
9.14.1 RS Synthesis Details
9.14.2 RS Synthesis Major Business
9.14.3 RS Synthesis Neurotransmitter Inhibitor Peptides Product and Services
9.14.4 RS Synthesis Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 RS Synthesis Recent Developments/Updates
9.14.6 RS Synthesis Competitive Strengths & Weaknesses
9.15 Shenzhen JYMed Technology Co., Ltd.
9.15.1 Shenzhen JYMed Technology Co., Ltd. Details
9.15.2 Shenzhen JYMed Technology Co., Ltd. Major Business
9.15.3 Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Product and Services
9.15.4 Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Shenzhen JYMed Technology Co., Ltd. Recent Developments/Updates
9.15.6 Shenzhen JYMed Technology Co., Ltd. Competitive Strengths & Weaknesses
9.16 Nanjing Peptide Biotech
9.16.1 Nanjing Peptide Biotech Details
9.16.2 Nanjing Peptide Biotech Major Business
9.16.3 Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.16.4 Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Nanjing Peptide Biotech Recent Developments/Updates
9.16.6 Nanjing Peptide Biotech Competitive Strengths & Weaknesses
9.17 AAPPTec
9.17.1 AAPPTec Details
9.17.2 AAPPTec Major Business
9.17.3 AAPPTec Neurotransmitter Inhibitor Peptides Product and Services
9.17.4 AAPPTec Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 AAPPTec Recent Developments/Updates
9.17.6 AAPPTec Competitive Strengths & Weaknesses
9.18 Tianji Bio-pharmaceutical
9.18.1 Tianji Bio-pharmaceutical Details
9.18.2 Tianji Bio-pharmaceutical Major Business
9.18.3 Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Product and Services
9.18.4 Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Tianji Bio-pharmaceutical Recent Developments/Updates
9.18.6 Tianji Bio-pharmaceutical Competitive Strengths & Weaknesses
9.19 Zhejiang Peptites Biotech
9.19.1 Zhejiang Peptites Biotech Details
9.19.2 Zhejiang Peptites Biotech Major Business
9.19.3 Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.19.4 Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Zhejiang Peptites Biotech Recent Developments/Updates
9.19.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
9.20 Guangzhou Tongjun Pharmaceutical Technology
9.20.1 Guangzhou Tongjun Pharmaceutical Technology Details
9.20.2 Guangzhou Tongjun Pharmaceutical Technology Major Business
9.20.3 Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Product and Services
9.20.4 Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Guangzhou Tongjun Pharmaceutical Technology Recent Developments/Updates
9.20.6 Guangzhou Tongjun Pharmaceutical Technology Competitive Strengths & Weaknesses
9.21 Hantide Biomedical Group
9.21.1 Hantide Biomedical Group Details
9.21.2 Hantide Biomedical Group Major Business
9.21.3 Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Product and Services
9.21.4 Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Hantide Biomedical Group Recent Developments/Updates
9.21.6 Hantide Biomedical Group Competitive Strengths & Weaknesses
9.22 Hangzhou Go Top Biotech
9.22.1 Hangzhou Go Top Biotech Details
9.22.2 Hangzhou Go Top Biotech Major Business
9.22.3 Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Product and Services
9.22.4 Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Hangzhou Go Top Biotech Recent Developments/Updates
9.22.6 Hangzhou Go Top Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neurotransmitter Inhibitor Peptides Industry Chain
10.2 Neurotransmitter Inhibitor Peptides Upstream Analysis
10.2.1 Neurotransmitter Inhibitor Peptides Core Raw Materials
10.2.2 Main Manufacturers of Neurotransmitter Inhibitor Peptides Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Neurotransmitter Inhibitor Peptides Production Mode
10.6 Neurotransmitter Inhibitor Peptides Procurement Model
10.7 Neurotransmitter Inhibitor Peptides Industry Sales Model and Sales Channels
10.7.1 Neurotransmitter Inhibitor Peptides Sales Model
10.7.2 Neurotransmitter Inhibitor Peptides Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Neurotransmitter Inhibitor Peptides Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Neurotransmitter Inhibitor Peptides Production Value by Region (2021-2026) & (USD Million)
Table 3. World Neurotransmitter Inhibitor Peptides Production Value by Region (2027-2032) & (USD Million)
Table 4. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2021-2026)
Table 5. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2027-2032)
Table 6. World Neurotransmitter Inhibitor Peptides Production by Region (2021-2026) & (kg)
Table 7. World Neurotransmitter Inhibitor Peptides Production by Region (2027-2032) & (kg)
Table 8. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2021-2026)
Table 9. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2027-2032)
Table 10. World Neurotransmitter Inhibitor Peptides Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Neurotransmitter Inhibitor Peptides Average Price by Region (2027-2032) & (US$/kg)
Table 12. Neurotransmitter Inhibitor Peptides Major Market Trends
Table 13. World Neurotransmitter Inhibitor Peptides Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (kg)
Table 14. World Neurotransmitter Inhibitor Peptides Consumption by Region (2021-2026) & (kg)
Table 15. World Neurotransmitter Inhibitor Peptides Consumption Forecast by Region (2027-2032) & (kg)
Table 16. World Neurotransmitter Inhibitor Peptides Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Neurotransmitter Inhibitor Peptides Producers in 2025
Table 18. World Neurotransmitter Inhibitor Peptides Production by Manufacturer (2021-2026) & (kg)
Table 19. Production Market Share of Key Neurotransmitter Inhibitor Peptides Producers in 2025
Table 20. World Neurotransmitter Inhibitor Peptides Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Neurotransmitter Inhibitor Peptides Company Evaluation Quadrant
Table 22. World Neurotransmitter Inhibitor Peptides Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Neurotransmitter Inhibitor Peptides Production Site of Key Manufacturer
Table 24. Neurotransmitter Inhibitor Peptides Market: Company Product Type Footprint
Table 25. Neurotransmitter Inhibitor Peptides Market: Company Product Application Footprint
Table 26. Neurotransmitter Inhibitor Peptides Competitive Factors
Table 27. Neurotransmitter Inhibitor Peptides New Entrant and Capacity Expansion Plans
Table 28. Neurotransmitter Inhibitor Peptides Mergers & Acquisitions Activity
Table 29. United States VS China Neurotransmitter Inhibitor Peptides Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Neurotransmitter Inhibitor Peptides Production Comparison, (2021 & 2025 & 2032) & (kg)
Table 31. United States VS China Neurotransmitter Inhibitor Peptides Consumption Comparison, (2021 & 2025 & 2032) & (kg)
Table 32. United States Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026) & (kg)
Table 36. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 37. China Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production, (2021-2026) & (kg)
Table 41. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 42. Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production, (2021-2026) & (kg)
Table 46. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 47. World Neurotransmitter Inhibitor Peptides Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Neurotransmitter Inhibitor Peptides Production by Type (2021-2026) & (kg)
Table 49. World Neurotransmitter Inhibitor Peptides Production by Type (2027-2032) & (kg)
Table 50. World Neurotransmitter Inhibitor Peptides Production Value by Type (2021-2026) & (USD Million)
Table 51. World Neurotransmitter Inhibitor Peptides Production Value by Type (2027-2032) & (USD Million)
Table 52. World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Neurotransmitter Inhibitor Peptides Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification, (USD Million), 2021 & 2025 & 2032
Table 55. World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2021-2026) & (kg)
Table 56. World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2027-2032) & (kg)
Table 57. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2021-2026) & (USD Million)
Table 58. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2027-2032) & (USD Million)
Table 59. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2026) & (US$/kg)
Table 60. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2027-2032) & (US$/kg)
Table 61. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length, (USD Million), 2021 & 2025 & 2032
Table 62. World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2021-2026) & (kg)
Table 63. World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2027-2032) & (kg)
Table 64. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2021-2026) & (USD Million)
Table 65. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2027-2032) & (USD Million)
Table 66. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2026) & (US$/kg)
Table 67. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2027-2032) & (US$/kg)
Table 68. World Neurotransmitter Inhibitor Peptides Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Neurotransmitter Inhibitor Peptides Production by Application (2021-2026) & (kg)
Table 70. World Neurotransmitter Inhibitor Peptides Production by Application (2027-2032) & (kg)
Table 71. World Neurotransmitter Inhibitor Peptides Production Value by Application (2021-2026) & (USD Million)
Table 72. World Neurotransmitter Inhibitor Peptides Production Value by Application (2027-2032) & (USD Million)
Table 73. World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Neurotransmitter Inhibitor Peptides Average Price by Application (2027-2032) & (US$/kg)
Table 75. Lubrizol (Lipotec) Basic Information, Manufacturing Base and Competitors
Table 76. Lubrizol (Lipotec) Major Business
Table 77. Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Product and Services
Table 78. Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Lubrizol (Lipotec) Recent Developments/Updates
Table 80. Lubrizol (Lipotec) Competitive Strengths & Weaknesses
Table 81. dsm-firmenich Basic Information, Manufacturing Base and Competitors
Table 82. dsm-firmenich Major Business
Table 83. dsm-firmenich Neurotransmitter Inhibitor Peptides Product and Services
Table 84. dsm-firmenich Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. dsm-firmenich Recent Developments/Updates
Table 86. dsm-firmenich Competitive Strengths & Weaknesses
Table 87. LipoTrue Basic Information, Manufacturing Base and Competitors
Table 88. LipoTrue Major Business
Table 89. LipoTrue Neurotransmitter Inhibitor Peptides Product and Services
Table 90. LipoTrue Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. LipoTrue Recent Developments/Updates
Table 92. LipoTrue Competitive Strengths & Weaknesses
Table 93. Spec-Chem Industry Basic Information, Manufacturing Base and Competitors
Table 94. Spec-Chem Industry Major Business
Table 95. Spec-Chem Industry Neurotransmitter Inhibitor Peptides Product and Services
Table 96. Spec-Chem Industry Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Spec-Chem Industry Recent Developments/Updates
Table 98. Spec-Chem Industry Competitive Strengths & Weaknesses
Table 99. GenScript Basic Information, Manufacturing Base and Competitors
Table 100. GenScript Major Business
Table 101. GenScript Neurotransmitter Inhibitor Peptides Product and Services
Table 102. GenScript Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. GenScript Recent Developments/Updates
Table 104. GenScript Competitive Strengths & Weaknesses
Table 105. Active Peptide Company Basic Information, Manufacturing Base and Competitors
Table 106. Active Peptide Company Major Business
Table 107. Active Peptide Company Neurotransmitter Inhibitor Peptides Product and Services
Table 108. Active Peptide Company Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Active Peptide Company Recent Developments/Updates
Table 110. Active Peptide Company Competitive Strengths & Weaknesses
Table 111. Uniproma Chemical Basic Information, Manufacturing Base and Competitors
Table 112. Uniproma Chemical Major Business
Table 113. Uniproma Chemical Neurotransmitter Inhibitor Peptides Product and Services
Table 114. Uniproma Chemical Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Uniproma Chemical Recent Developments/Updates
Table 116. Uniproma Chemical Competitive Strengths & Weaknesses
Table 117. BOC Sciences (AAPEP) Basic Information, Manufacturing Base and Competitors
Table 118. BOC Sciences (AAPEP) Major Business
Table 119. BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Product and Services
Table 120. BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. BOC Sciences (AAPEP) Recent Developments/Updates
Table 122. BOC Sciences (AAPEP) Competitive Strengths & Weaknesses
Table 123. GfN Selco Basic Information, Manufacturing Base and Competitors
Table 124. GfN Selco Major Business
Table 125. GfN Selco Neurotransmitter Inhibitor Peptides Product and Services
Table 126. GfN Selco Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. GfN Selco Recent Developments/Updates
Table 128. GfN Selco Competitive Strengths & Weaknesses
Table 129. COSROMA Basic Information, Manufacturing Base and Competitors
Table 130. COSROMA Major Business
Table 131. COSROMA Neurotransmitter Inhibitor Peptides Product and Services
Table 132. COSROMA Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. COSROMA Recent Developments/Updates
Table 134. COSROMA Competitive Strengths & Weaknesses
Table 135. Gene-Biocon Basic Information, Manufacturing Base and Competitors
Table 136. Gene-Biocon Major Business
Table 137. Gene-Biocon Neurotransmitter Inhibitor Peptides Product and Services
Table 138. Gene-Biocon Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Gene-Biocon Recent Developments/Updates
Table 140. Gene-Biocon Competitive Strengths & Weaknesses
Table 141. ChinaPeptides (QYAOBIO) Basic Information, Manufacturing Base and Competitors
Table 142. ChinaPeptides (QYAOBIO) Major Business
Table 143. ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Product and Services
Table 144. ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. ChinaPeptides (QYAOBIO) Recent Developments/Updates
Table 146. ChinaPeptides (QYAOBIO) Competitive Strengths & Weaknesses
Table 147. Pengting Peptide Basic Information, Manufacturing Base and Competitors
Table 148. Pengting Peptide Major Business
Table 149. Pengting Peptide Neurotransmitter Inhibitor Peptides Product and Services
Table 150. Pengting Peptide Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Pengting Peptide Recent Developments/Updates
Table 152. Pengting Peptide Competitive Strengths & Weaknesses
Table 153. RS Synthesis Basic Information, Manufacturing Base and Competitors
Table 154. RS Synthesis Major Business
Table 155. RS Synthesis Neurotransmitter Inhibitor Peptides Product and Services
Table 156. RS Synthesis Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. RS Synthesis Recent Developments/Updates
Table 158. RS Synthesis Competitive Strengths & Weaknesses
Table 159. Shenzhen JYMed Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Shenzhen JYMed Technology Co., Ltd. Major Business
Table 161. Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Product and Services
Table 162. Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Shenzhen JYMed Technology Co., Ltd. Recent Developments/Updates
Table 164. Shenzhen JYMed Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Nanjing Peptide Biotech Basic Information, Manufacturing Base and Competitors
Table 166. Nanjing Peptide Biotech Major Business
Table 167. Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 168. Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Nanjing Peptide Biotech Recent Developments/Updates
Table 170. Nanjing Peptide Biotech Competitive Strengths & Weaknesses
Table 171. AAPPTec Basic Information, Manufacturing Base and Competitors
Table 172. AAPPTec Major Business
Table 173. AAPPTec Neurotransmitter Inhibitor Peptides Product and Services
Table 174. AAPPTec Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. AAPPTec Recent Developments/Updates
Table 176. AAPPTec Competitive Strengths & Weaknesses
Table 177. Tianji Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 178. Tianji Bio-pharmaceutical Major Business
Table 179. Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Product and Services
Table 180. Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Tianji Bio-pharmaceutical Recent Developments/Updates
Table 182. Tianji Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 183. Zhejiang Peptites Biotech Basic Information, Manufacturing Base and Competitors
Table 184. Zhejiang Peptites Biotech Major Business
Table 185. Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 186. Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Zhejiang Peptites Biotech Recent Developments/Updates
Table 188. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 189. Guangzhou Tongjun Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 190. Guangzhou Tongjun Pharmaceutical Technology Major Business
Table 191. Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Product and Services
Table 192. Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Guangzhou Tongjun Pharmaceutical Technology Recent Developments/Updates
Table 194. Guangzhou Tongjun Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 195. Hantide Biomedical Group Basic Information, Manufacturing Base and Competitors
Table 196. Hantide Biomedical Group Major Business
Table 197. Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Product and Services
Table 198. Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Hantide Biomedical Group Recent Developments/Updates
Table 200. Hantide Biomedical Group Competitive Strengths & Weaknesses
Table 201. Hangzhou Go Top Biotech Basic Information, Manufacturing Base and Competitors
Table 202. Hangzhou Go Top Biotech Major Business
Table 203. Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 204. Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Hangzhou Go Top Biotech Recent Developments/Updates
Table 206. Hangzhou Go Top Biotech Competitive Strengths & Weaknesses
Table 207. Global Key Players of Neurotransmitter Inhibitor Peptides Upstream (Raw Materials)
Table 208. Global Neurotransmitter Inhibitor Peptides Typical Customers
Table 209. Neurotransmitter Inhibitor Peptides Typical Distributors
Table 1. World Neurotransmitter Inhibitor Peptides Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Neurotransmitter Inhibitor Peptides Production Value by Region (2021-2026) & (USD Million)
Table 3. World Neurotransmitter Inhibitor Peptides Production Value by Region (2027-2032) & (USD Million)
Table 4. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2021-2026)
Table 5. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2027-2032)
Table 6. World Neurotransmitter Inhibitor Peptides Production by Region (2021-2026) & (kg)
Table 7. World Neurotransmitter Inhibitor Peptides Production by Region (2027-2032) & (kg)
Table 8. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2021-2026)
Table 9. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2027-2032)
Table 10. World Neurotransmitter Inhibitor Peptides Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Neurotransmitter Inhibitor Peptides Average Price by Region (2027-2032) & (US$/kg)
Table 12. Neurotransmitter Inhibitor Peptides Major Market Trends
Table 13. World Neurotransmitter Inhibitor Peptides Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (kg)
Table 14. World Neurotransmitter Inhibitor Peptides Consumption by Region (2021-2026) & (kg)
Table 15. World Neurotransmitter Inhibitor Peptides Consumption Forecast by Region (2027-2032) & (kg)
Table 16. World Neurotransmitter Inhibitor Peptides Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Neurotransmitter Inhibitor Peptides Producers in 2025
Table 18. World Neurotransmitter Inhibitor Peptides Production by Manufacturer (2021-2026) & (kg)
Table 19. Production Market Share of Key Neurotransmitter Inhibitor Peptides Producers in 2025
Table 20. World Neurotransmitter Inhibitor Peptides Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Neurotransmitter Inhibitor Peptides Company Evaluation Quadrant
Table 22. World Neurotransmitter Inhibitor Peptides Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Neurotransmitter Inhibitor Peptides Production Site of Key Manufacturer
Table 24. Neurotransmitter Inhibitor Peptides Market: Company Product Type Footprint
Table 25. Neurotransmitter Inhibitor Peptides Market: Company Product Application Footprint
Table 26. Neurotransmitter Inhibitor Peptides Competitive Factors
Table 27. Neurotransmitter Inhibitor Peptides New Entrant and Capacity Expansion Plans
Table 28. Neurotransmitter Inhibitor Peptides Mergers & Acquisitions Activity
Table 29. United States VS China Neurotransmitter Inhibitor Peptides Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Neurotransmitter Inhibitor Peptides Production Comparison, (2021 & 2025 & 2032) & (kg)
Table 31. United States VS China Neurotransmitter Inhibitor Peptides Consumption Comparison, (2021 & 2025 & 2032) & (kg)
Table 32. United States Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production (2021-2026) & (kg)
Table 36. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 37. China Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production, (2021-2026) & (kg)
Table 41. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 42. Rest of World Based Neurotransmitter Inhibitor Peptides Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production, (2021-2026) & (kg)
Table 46. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share (2021-2026)
Table 47. World Neurotransmitter Inhibitor Peptides Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Neurotransmitter Inhibitor Peptides Production by Type (2021-2026) & (kg)
Table 49. World Neurotransmitter Inhibitor Peptides Production by Type (2027-2032) & (kg)
Table 50. World Neurotransmitter Inhibitor Peptides Production Value by Type (2021-2026) & (USD Million)
Table 51. World Neurotransmitter Inhibitor Peptides Production Value by Type (2027-2032) & (USD Million)
Table 52. World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Neurotransmitter Inhibitor Peptides Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification, (USD Million), 2021 & 2025 & 2032
Table 55. World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2021-2026) & (kg)
Table 56. World Neurotransmitter Inhibitor Peptides Production by Chemical Modification (2027-2032) & (kg)
Table 57. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2021-2026) & (USD Million)
Table 58. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification (2027-2032) & (USD Million)
Table 59. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2026) & (US$/kg)
Table 60. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2027-2032) & (US$/kg)
Table 61. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length, (USD Million), 2021 & 2025 & 2032
Table 62. World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2021-2026) & (kg)
Table 63. World Neurotransmitter Inhibitor Peptides Production by Peptide Chain Length (2027-2032) & (kg)
Table 64. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2021-2026) & (USD Million)
Table 65. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length (2027-2032) & (USD Million)
Table 66. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2026) & (US$/kg)
Table 67. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2027-2032) & (US$/kg)
Table 68. World Neurotransmitter Inhibitor Peptides Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Neurotransmitter Inhibitor Peptides Production by Application (2021-2026) & (kg)
Table 70. World Neurotransmitter Inhibitor Peptides Production by Application (2027-2032) & (kg)
Table 71. World Neurotransmitter Inhibitor Peptides Production Value by Application (2021-2026) & (USD Million)
Table 72. World Neurotransmitter Inhibitor Peptides Production Value by Application (2027-2032) & (USD Million)
Table 73. World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Neurotransmitter Inhibitor Peptides Average Price by Application (2027-2032) & (US$/kg)
Table 75. Lubrizol (Lipotec) Basic Information, Manufacturing Base and Competitors
Table 76. Lubrizol (Lipotec) Major Business
Table 77. Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Product and Services
Table 78. Lubrizol (Lipotec) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Lubrizol (Lipotec) Recent Developments/Updates
Table 80. Lubrizol (Lipotec) Competitive Strengths & Weaknesses
Table 81. dsm-firmenich Basic Information, Manufacturing Base and Competitors
Table 82. dsm-firmenich Major Business
Table 83. dsm-firmenich Neurotransmitter Inhibitor Peptides Product and Services
Table 84. dsm-firmenich Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. dsm-firmenich Recent Developments/Updates
Table 86. dsm-firmenich Competitive Strengths & Weaknesses
Table 87. LipoTrue Basic Information, Manufacturing Base and Competitors
Table 88. LipoTrue Major Business
Table 89. LipoTrue Neurotransmitter Inhibitor Peptides Product and Services
Table 90. LipoTrue Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. LipoTrue Recent Developments/Updates
Table 92. LipoTrue Competitive Strengths & Weaknesses
Table 93. Spec-Chem Industry Basic Information, Manufacturing Base and Competitors
Table 94. Spec-Chem Industry Major Business
Table 95. Spec-Chem Industry Neurotransmitter Inhibitor Peptides Product and Services
Table 96. Spec-Chem Industry Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Spec-Chem Industry Recent Developments/Updates
Table 98. Spec-Chem Industry Competitive Strengths & Weaknesses
Table 99. GenScript Basic Information, Manufacturing Base and Competitors
Table 100. GenScript Major Business
Table 101. GenScript Neurotransmitter Inhibitor Peptides Product and Services
Table 102. GenScript Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. GenScript Recent Developments/Updates
Table 104. GenScript Competitive Strengths & Weaknesses
Table 105. Active Peptide Company Basic Information, Manufacturing Base and Competitors
Table 106. Active Peptide Company Major Business
Table 107. Active Peptide Company Neurotransmitter Inhibitor Peptides Product and Services
Table 108. Active Peptide Company Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Active Peptide Company Recent Developments/Updates
Table 110. Active Peptide Company Competitive Strengths & Weaknesses
Table 111. Uniproma Chemical Basic Information, Manufacturing Base and Competitors
Table 112. Uniproma Chemical Major Business
Table 113. Uniproma Chemical Neurotransmitter Inhibitor Peptides Product and Services
Table 114. Uniproma Chemical Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Uniproma Chemical Recent Developments/Updates
Table 116. Uniproma Chemical Competitive Strengths & Weaknesses
Table 117. BOC Sciences (AAPEP) Basic Information, Manufacturing Base and Competitors
Table 118. BOC Sciences (AAPEP) Major Business
Table 119. BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Product and Services
Table 120. BOC Sciences (AAPEP) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. BOC Sciences (AAPEP) Recent Developments/Updates
Table 122. BOC Sciences (AAPEP) Competitive Strengths & Weaknesses
Table 123. GfN Selco Basic Information, Manufacturing Base and Competitors
Table 124. GfN Selco Major Business
Table 125. GfN Selco Neurotransmitter Inhibitor Peptides Product and Services
Table 126. GfN Selco Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. GfN Selco Recent Developments/Updates
Table 128. GfN Selco Competitive Strengths & Weaknesses
Table 129. COSROMA Basic Information, Manufacturing Base and Competitors
Table 130. COSROMA Major Business
Table 131. COSROMA Neurotransmitter Inhibitor Peptides Product and Services
Table 132. COSROMA Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. COSROMA Recent Developments/Updates
Table 134. COSROMA Competitive Strengths & Weaknesses
Table 135. Gene-Biocon Basic Information, Manufacturing Base and Competitors
Table 136. Gene-Biocon Major Business
Table 137. Gene-Biocon Neurotransmitter Inhibitor Peptides Product and Services
Table 138. Gene-Biocon Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Gene-Biocon Recent Developments/Updates
Table 140. Gene-Biocon Competitive Strengths & Weaknesses
Table 141. ChinaPeptides (QYAOBIO) Basic Information, Manufacturing Base and Competitors
Table 142. ChinaPeptides (QYAOBIO) Major Business
Table 143. ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Product and Services
Table 144. ChinaPeptides (QYAOBIO) Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. ChinaPeptides (QYAOBIO) Recent Developments/Updates
Table 146. ChinaPeptides (QYAOBIO) Competitive Strengths & Weaknesses
Table 147. Pengting Peptide Basic Information, Manufacturing Base and Competitors
Table 148. Pengting Peptide Major Business
Table 149. Pengting Peptide Neurotransmitter Inhibitor Peptides Product and Services
Table 150. Pengting Peptide Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Pengting Peptide Recent Developments/Updates
Table 152. Pengting Peptide Competitive Strengths & Weaknesses
Table 153. RS Synthesis Basic Information, Manufacturing Base and Competitors
Table 154. RS Synthesis Major Business
Table 155. RS Synthesis Neurotransmitter Inhibitor Peptides Product and Services
Table 156. RS Synthesis Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. RS Synthesis Recent Developments/Updates
Table 158. RS Synthesis Competitive Strengths & Weaknesses
Table 159. Shenzhen JYMed Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Shenzhen JYMed Technology Co., Ltd. Major Business
Table 161. Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Product and Services
Table 162. Shenzhen JYMed Technology Co., Ltd. Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Shenzhen JYMed Technology Co., Ltd. Recent Developments/Updates
Table 164. Shenzhen JYMed Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Nanjing Peptide Biotech Basic Information, Manufacturing Base and Competitors
Table 166. Nanjing Peptide Biotech Major Business
Table 167. Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 168. Nanjing Peptide Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Nanjing Peptide Biotech Recent Developments/Updates
Table 170. Nanjing Peptide Biotech Competitive Strengths & Weaknesses
Table 171. AAPPTec Basic Information, Manufacturing Base and Competitors
Table 172. AAPPTec Major Business
Table 173. AAPPTec Neurotransmitter Inhibitor Peptides Product and Services
Table 174. AAPPTec Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. AAPPTec Recent Developments/Updates
Table 176. AAPPTec Competitive Strengths & Weaknesses
Table 177. Tianji Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 178. Tianji Bio-pharmaceutical Major Business
Table 179. Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Product and Services
Table 180. Tianji Bio-pharmaceutical Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Tianji Bio-pharmaceutical Recent Developments/Updates
Table 182. Tianji Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 183. Zhejiang Peptites Biotech Basic Information, Manufacturing Base and Competitors
Table 184. Zhejiang Peptites Biotech Major Business
Table 185. Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 186. Zhejiang Peptites Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Zhejiang Peptites Biotech Recent Developments/Updates
Table 188. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 189. Guangzhou Tongjun Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 190. Guangzhou Tongjun Pharmaceutical Technology Major Business
Table 191. Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Product and Services
Table 192. Guangzhou Tongjun Pharmaceutical Technology Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Guangzhou Tongjun Pharmaceutical Technology Recent Developments/Updates
Table 194. Guangzhou Tongjun Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 195. Hantide Biomedical Group Basic Information, Manufacturing Base and Competitors
Table 196. Hantide Biomedical Group Major Business
Table 197. Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Product and Services
Table 198. Hantide Biomedical Group Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Hantide Biomedical Group Recent Developments/Updates
Table 200. Hantide Biomedical Group Competitive Strengths & Weaknesses
Table 201. Hangzhou Go Top Biotech Basic Information, Manufacturing Base and Competitors
Table 202. Hangzhou Go Top Biotech Major Business
Table 203. Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Product and Services
Table 204. Hangzhou Go Top Biotech Neurotransmitter Inhibitor Peptides Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Hangzhou Go Top Biotech Recent Developments/Updates
Table 206. Hangzhou Go Top Biotech Competitive Strengths & Weaknesses
Table 207. Global Key Players of Neurotransmitter Inhibitor Peptides Upstream (Raw Materials)
Table 208. Global Neurotransmitter Inhibitor Peptides Typical Customers
Table 209. Neurotransmitter Inhibitor Peptides Typical Distributors
LIST OF FIGURES
Figure 1. Neurotransmitter Inhibitor Peptides Picture
Figure 2. World Neurotransmitter Inhibitor Peptides Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neurotransmitter Inhibitor Peptides Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 5. World Neurotransmitter Inhibitor Peptides Average Price (2021-2032) & (US$/kg)
Figure 6. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2021-2032)
Figure 7. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2021-2032)
Figure 8. North America Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 9. Europe Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 10. China Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 11. Japan Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 12. India Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 13. Southeast Asia Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 14. Neurotransmitter Inhibitor Peptides Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 17. World Neurotransmitter Inhibitor Peptides Consumption Market Share by Region (2021-2032)
Figure 18. United States Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 19. China Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 20. Europe Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 21. Japan Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 22. South Korea Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 23. ASEAN Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 24. India Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 25. Producer Shipments of Neurotransmitter Inhibitor Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Neurotransmitter Inhibitor Peptides Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Neurotransmitter Inhibitor Peptides Markets in 2025
Figure 28. United States VS China: Neurotransmitter Inhibitor Peptides Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Neurotransmitter Inhibitor Peptides Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Neurotransmitter Inhibitor Peptides Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 32. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 34. World Neurotransmitter Inhibitor Peptides Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Type in 2025
Figure 36. SNARE-Complex Modulating Peptides
Figure 37. SNAP-25 Mimicking Peptides
Figure 38. Others
Figure 39. World Neurotransmitter Inhibitor Peptides Production Market Share by Type (2021-2032)
Figure 40. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Type (2021-2032)
Figure 41. World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2032) & (US$/kg)
Figure 42. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification, (USD Million), 2021 & 2025 & 2032
Figure 43. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Chemical Modification in 2025
Figure 44. Unmodified Peptides
Figure 45. Acetylated Peptides
Figure 46. Other
Figure 47. World Neurotransmitter Inhibitor Peptides Production Market Share by Chemical Modification (2021-2032)
Figure 48. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Chemical Modification (2021-2032)
Figure 49. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2032) & (US$/kg)
Figure 50. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length, (USD Million), 2021 & 2025 & 2032
Figure 51. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Peptide Chain Length in 2025
Figure 52. Short-Chain Peptides: 2?4 Amino Acids
Figure 53. Medium-Chain Peptides: 5?8 Amino Acids
Figure 54. Long-Chain Peptides: >8 Amino Acids
Figure 55. World Neurotransmitter Inhibitor Peptides Production Market Share by Peptide Chain Length (2021-2032)
Figure 56. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Peptide Chain Length (2021-2032)
Figure 57. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2032) & (US$/kg)
Figure 58. World Neurotransmitter Inhibitor Peptides Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Application in 2025
Figure 60. Eye Care Products
Figure 61. Facial Serums
Figure 62. Face Creams and Lotions
Figure 63. Other
Figure 64. World Neurotransmitter Inhibitor Peptides Production Market Share by Application (2021-2032)
Figure 65. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Application (2021-2032)
Figure 66. World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2032) & (US$/kg)
Figure 67. Neurotransmitter Inhibitor Peptides Industry Chain
Figure 68. Neurotransmitter Inhibitor Peptides Procurement Model
Figure 69. Neurotransmitter Inhibitor Peptides Sales Model
Figure 70. Neurotransmitter Inhibitor Peptides Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Neurotransmitter Inhibitor Peptides Picture
Figure 2. World Neurotransmitter Inhibitor Peptides Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neurotransmitter Inhibitor Peptides Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 5. World Neurotransmitter Inhibitor Peptides Average Price (2021-2032) & (US$/kg)
Figure 6. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Region (2021-2032)
Figure 7. World Neurotransmitter Inhibitor Peptides Production Market Share by Region (2021-2032)
Figure 8. North America Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 9. Europe Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 10. China Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 11. Japan Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 12. India Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 13. Southeast Asia Neurotransmitter Inhibitor Peptides Production (2021-2032) & (kg)
Figure 14. Neurotransmitter Inhibitor Peptides Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 17. World Neurotransmitter Inhibitor Peptides Consumption Market Share by Region (2021-2032)
Figure 18. United States Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 19. China Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 20. Europe Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 21. Japan Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 22. South Korea Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 23. ASEAN Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 24. India Neurotransmitter Inhibitor Peptides Consumption (2021-2032) & (kg)
Figure 25. Producer Shipments of Neurotransmitter Inhibitor Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Neurotransmitter Inhibitor Peptides Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Neurotransmitter Inhibitor Peptides Markets in 2025
Figure 28. United States VS China: Neurotransmitter Inhibitor Peptides Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Neurotransmitter Inhibitor Peptides Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Neurotransmitter Inhibitor Peptides Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 32. China Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Neurotransmitter Inhibitor Peptides Production Market Share 2025
Figure 34. World Neurotransmitter Inhibitor Peptides Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Type in 2025
Figure 36. SNARE-Complex Modulating Peptides
Figure 37. SNAP-25 Mimicking Peptides
Figure 38. Others
Figure 39. World Neurotransmitter Inhibitor Peptides Production Market Share by Type (2021-2032)
Figure 40. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Type (2021-2032)
Figure 41. World Neurotransmitter Inhibitor Peptides Average Price by Type (2021-2032) & (US$/kg)
Figure 42. World Neurotransmitter Inhibitor Peptides Production Value by Chemical Modification, (USD Million), 2021 & 2025 & 2032
Figure 43. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Chemical Modification in 2025
Figure 44. Unmodified Peptides
Figure 45. Acetylated Peptides
Figure 46. Other
Figure 47. World Neurotransmitter Inhibitor Peptides Production Market Share by Chemical Modification (2021-2032)
Figure 48. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Chemical Modification (2021-2032)
Figure 49. World Neurotransmitter Inhibitor Peptides Average Price by Chemical Modification (2021-2032) & (US$/kg)
Figure 50. World Neurotransmitter Inhibitor Peptides Production Value by Peptide Chain Length, (USD Million), 2021 & 2025 & 2032
Figure 51. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Peptide Chain Length in 2025
Figure 52. Short-Chain Peptides: 2?4 Amino Acids
Figure 53. Medium-Chain Peptides: 5?8 Amino Acids
Figure 54. Long-Chain Peptides: >8 Amino Acids
Figure 55. World Neurotransmitter Inhibitor Peptides Production Market Share by Peptide Chain Length (2021-2032)
Figure 56. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Peptide Chain Length (2021-2032)
Figure 57. World Neurotransmitter Inhibitor Peptides Average Price by Peptide Chain Length (2021-2032) & (US$/kg)
Figure 58. World Neurotransmitter Inhibitor Peptides Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Application in 2025
Figure 60. Eye Care Products
Figure 61. Facial Serums
Figure 62. Face Creams and Lotions
Figure 63. Other
Figure 64. World Neurotransmitter Inhibitor Peptides Production Market Share by Application (2021-2032)
Figure 65. World Neurotransmitter Inhibitor Peptides Production Value Market Share by Application (2021-2032)
Figure 66. World Neurotransmitter Inhibitor Peptides Average Price by Application (2021-2032) & (US$/kg)
Figure 67. Neurotransmitter Inhibitor Peptides Industry Chain
Figure 68. Neurotransmitter Inhibitor Peptides Procurement Model
Figure 69. Neurotransmitter Inhibitor Peptides Sales Model
Figure 70. Neurotransmitter Inhibitor Peptides Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
